Home » NDASA News

NDASA News

Featured posts

What if Marijuana Becomes a Schedule III Drug?

By Jonathan Baktari, MD, US Drug Test Centers With evolving legislation, the legalization of certain drugs continues to change. There have been a lot of question marks around THC, the psychoactive substance in marijuana. Over the years, we’ve watched as the...

Are you coming to NDASA’s 2025 Conference? Share your excitement

Let your professional contacts and industry colleagues know that you will be attending, sponsoring, training, speaking or exhibiting at NDASA's 2025 Conference & Tradeshow in Jacksonville this April by posting on social media. Attendees, exhibitors, sponsors,...

The state of drug testing across the nation

By Jonathan Baktari, MD, CEO of US Drug Test Centers The laws surrounding drug use and employment drug testing are rapidly changing, and many individuals and companies are having a hard time keeping up. The change, though, is needed: With marijuana use for both...

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.

All posts

In memoriam: a tribute to Joe Plaia

In memoriam: a tribute to Joe Plaia

The National Drug and Alcohol Screening Association and the entire drug testing industry lost one of the all-time greatest of our profession when dear friend and associate Joe Plaia of Alabama passed away July 7 at the age of 72. Joe worked for more than 30 years at...

NDASA Board of Director nominations due

NDASA Board of Director nominations due

The Class of 2024 Board of Director seats are now open for applicants.ELEVEN seats must be filled. Service terms are 3 years. CANDIDATE QUALIFICATIONS: Be NDASA members in good standing prior to the date of voting. Have at least 5 years of experience in an...